The a-chain of the core oligosaccharide of the lipo-oligosaccharide (LOS) produced by Neisseria gonorrhoeae can undergo reversible and rapid changes in structure due to phase-variable production of certain enzymes employed in the biosynthesis of the lacto-N-neotetraose structure. Five of these enzymes are encoded by the lgtABCDE operon, and polynucleotide tracts within three of these genes (lgtA, lgtC and lgtD) can be substrates for slipped-strand mispairing events that lead to nucleotide insertions or deletion events which result in variable production of their respective gene products. We now report that phase-variable synthesis of the lgtA and lgtC gene products in strain FA19 results in the production of elongated LOS a-chains and that the presence of these LOS species can result in gonococci being sensitive to the bacteriolytic action of serum-antibody and complement. Hence, phase variation within the lgtABCDE operon can significantly impact the ability of gonococci to subvert this important host defense system.
INTRODUCTION
Neisseria gonorrhoeae is a strict human pathogen that has caused the sexually transmitted disease gonorrhoea for thousands of years. 1 This long-term relationship between gonococci and the human host coupled with the capacity of humans to have repeated gonococcal infections suggest that this pathogen has developed mechanisms to resist the constitutive and inducible host defense mechanisms that may become available during infection. Gonococcal resistance to humoral defense mechanisms (antibody and complement) includes production of an IgA1 protease, 2 molecular mimicry of host antigens, 3 production of blocking antibody against the reduction-modifiable outer membrane protein, 4 and phase and/or antigenic variation of gonococcal surface antigens that could serve as sites for bactericidal or opsonic antibodies. 5 Phase-variable production of pilin 6 (the main building block of the virulence-associated pilus structure), opacity-related outer membrane proteins 7 (Opas), and species of lipo-oligosaccharide (LOS) [8] [9] [10] [11] [12] are the best documented and studied examples of high-frequency changes in surface antigens that are of likely importance in the interaction of gonococci with host cells and resistance to cellular and humoral defenses.
Normal human serum (NHS) can exhibit potent antigonococcal activity in vitro. [13] [14] [15] [16] [17] [18] [19] This activity appears to be dependent on a natural IgM antibody and the classical pathway of complement. 18, 19 However, strains isolated from patients with invasive bloodstream disease (disseminated gonococcal infection [DGI] ) typically express stable resistance to the bacteriolytic action of NHS, even after repeated passage in vitro. 13 In contrast, strains isolated from patients with urogenital infections are normally NHS-sensitive. 14 However, if NHS-sensitive strains contain a terminal galactose in their LOS a-chain, the transfer of sialic acid from cytidine monophospho-N-acetyl neuraminic acid (CMP-NANA) to this carbohydrate 15 can result in transient, unstable NHS-resistance. 16 Stable NHS-resistance in gonococci may also involve structural changes in LOS. Thus, gonococci producing a 3.6 kDa LOS have been reported to be more likely to be NHS-resistant, while those producing larger LOS species are often NHS-sensitive. [17] [18] [19] The LOS side-chains responsible for the production of multiple species in vitro [9] [10] [11] or in vivo 20 can change in length and carbohydrate composition due to phase-variable expression of LOS biosynthetic genes. The lgtABCDE operon, originally described by Gotschlich, 21 encodes enzymes responsible for extension of the LOS a-chain, and three of the genes (lgtA, lgtC and lgtD) contain homopolymeric G nucleotide tracts that are subject to phase-variable expression. Single nucleotide deletions or insertions in these genes due to slipped-strand mispairing events can place these genes in or out of frame, 8, 21 resulting in variable production of full-length and functional enzymes. We now report that phase-variable expression of two genes within the lgtABCDE operon (lgtA and lgtC) can significantly impact the susceptibility of gonococci to the bacteriolytic action of NHS.
MATERIALS AND METHODS

Gonococcal strains used and growth conditions
The isolate of N. gonorrhoeae strain FA19 used in our previous study, 19 along with its transformant strains SS-1, SS-2 and SS-9, were propagated from freezer (-70°C) vial stocks that had been maintained since 1987 19 at 37°C under 3.8% (v/v) CO 2 on Gonococcal Base Agar (GCB; Difco Laboratories, Detroit, MI, USA) containing defined supplements I and II. Although strain FA19 can produce multiple LOS species of 3.6, 4.3 and 4.5 kDa, 22 the culture that served as the parental strain for construction of strains SS-1, SS-2 and SS-9 produced the 3.6 kDa species as the predominant LOS ( Fig. 1 and Table 1 ). SS-1 retained the NHS-resistant property of strain FA19 (Table 1 ). In contrast, strain SS-2 is highly NHS-sensitive (0.03% survival after 60 min in 50% [v/v] NHS), while strain SS-9 displayed an intermediate NHS-susceptibility profile (37% survival under the above described conditions).
Bactericidal assays
The serum bactericidal assay (SBA) used in this study has been described previously. 19 All assays were repeated at least twice using mid-logarithmic phase broth cultures of non-piliated, opacity-negative colony variants. The percentage of gonococci (10 6 colony forming units [CFU] per ml) surviving in 33% or 50% (v/v) NHS after 30 min at 37°C was determined based on the input of gonococci in the SBA. The SBA was modified to isolate spontaneous NHS-resistant variants of strain SS-2 by exposing 50 ml of a gonococcal suspension (10 7 CFU/ml) in 0.2x GCB broth to 50 ml of NHS for 1 h, followed by the addition of 50 ml of NHS for a second round of incubation. After 1 h incubation, NHS-treated and untreated cultures were plated onto GCB agar. Colonies from both cultures were propagated on GCB agar and retested for their susceptibility to NHS. The susceptibility of . LOS was prepared from strains by proteinase K digestion of whole gonococci. 22 The samples were subjected to SDS-PAGE 23 strains to human antibacterial peptide LL-37 and polymyxin B (Sigma Chemical Co., St Louis, MO, USA) was determined as described by Shafer et al. 22 Electrophoretic and immunoblotting analyses of LOS Proteinase K digests of whole gonococci were prepared 23 and subjected to Tricine SDS-PAGE as described previously. 24 The gels were stained with silver to visualize LOS or electroblotted to polyvinylidene difluoride (PVDF) membranes for subsequent probing 25 with monoclonal antibodies (mAbs) 4C4 and 3F11 (Table 1) . mAb 4C4 recognizes the Glcb1-4HepI epitope of gonococcal strains 1291c, 25 while mAb 3F11 is specific for the Galb1-4Glc NAc 26-28 epitope within the lacto-N-neotetraose region of the LOS a-chain.
Preparation of oligosaccharides (OSs) from the LOS
For chemical analysis, LOS was purified from gonococcal strains as described previously. 25 Contaminating phospholipids were extracted from LOS by suspending the LOS in 3:1 (v/v) chloroform:methanol, and stirring for 30 min at room temperature. Briefly, the presence of phospholipids in the crude LOS preparations was indicated by significant levels of PL-specific fatty acyl components which, in the case of N. gonorrhoeae, 29 are C14:0, C16:1, C16:0 and C18:1. The crude LOS was extracted as described to remove the contaminating PL and was judged to be complete when fatty acid analysis showed that the PL-specific fatty acyl groups were absent and the LOS-specific glycosyl residues and fatty acyl substituents (3-OHC12:0, 3OH-C14:0, and C12:0) were present. The suspension was centrifuged at 10,000 g in a JA-20 rotor (Beckman) at 4°C for 20 min. The supernatant was removed and the pellet was extracted repeatedly with the solvent mixture as before until free from phospholipid. The resulting pellet was then dissolved in water and lyophilized. The purified LOS was hydrolyzed in aqueous 1% (v/v) acetic acid for 2 h at 100°C. The hydrolysate was centrifuged at 10,000 g for 20 min, and the supernatant was collected. The pellet was washed once with water and centrifuged again. The water wash was added to the supernatant, and the total aqueous phase, containing the OSs, was lyophilized. The lyophilized OSs were dissolved in water and applied to a Bio-Gel P-2 column (70 x 1.6 cm), and eluted with water containing 1% (v/v) 1-butanol. Fractions were assayed for carbohydrate by phenol-sulfuric acid assay. 25 Fractions representing the OS peaks were pooled and lyophilized. Each OS fraction was then treated with cold aqueous 48% hydrogen fluoride (HF) and kept for 48 h at 4°C. The HF was removed by flushing under a stream of air followed by the addition of diethyl ether (600 ml) and drying with a stream of air. This step was repeated three times and the resulting residue was dissolved in deionized water at 4°C and the fluid was lyophilized.
Glycosyl composition and linkage analysis of the oligosaccharides
The glycosyl composition of each OS was determined by hydrolysis in 2 M trifluoroacetic acid (TFA) in a closed vial at 120°C for 3 h. The resulting glycoses in the hydrolysate were reduced with NaBH 4 , acetylated, and were analyzed by GLC-MS. 30 Glycosyl linkage analyses were carried out using a modified NaOH method. 31 Samples were dissolved in dimethyl sulphoxide, powdered NaOH was added, and the reaction mixture was stirred rapidly for 30 min. Methylation was performed by the sequential additions of iodomethane (10, 20 and 30 ml) at 10 min intervals. After stirring for an additional 30 min, the methylated glycans were recovered in the organic phase after addition of chloroform (0.5 ml 3 ) and 1 M sodium thiosulfate. The permethylated product was further purified by reverse-phase chromatography on a Sep-Pak C 18 cartridge. 31 The permethylated glycans were hydrolyzed with 2 M TFA (120°C, 2 h), reduced with NaBH 4 , acetylated, and analyzed by GLC-MS. 29 GLC and GLC-MS analyses were performed using a 30 m capillary DB-5 column (J & W Scientific) for aminoglycosyl derivatives, and a 30 m capillary SP2330 column (Supelco) for neutral glycose derivatives.
Mass spectrometry
OSs were analyzed by MALDI-TOF mass spectrometry using a Hewlett Packard LD-TOF system. The OSs were dissolved in distilled water at a final concentration of 2 mg/ml, and 1 ml was mixed with the DHB (dihydroxybenzoic acid in methanol) matrix for analysis. Spectra were acquired in the negative mode. Tandem MS/MS analysis was performed using a Q-TOF hybrid mass spectrometer (Q-TOFII; Micromass, UK) equipped with an electrospray source (Z-spray) operated in the positive mode. The samples were dissolved in deionized water and infused into the mass spectrometer with a syringe pump (Harvard Apparatus, Cambridge, MA, USA) at a flow rate of 5 ml/min. A potential of 3 kV was applied to the capillary, and nitrogen was employed as both the drying and nebulization gas. NaI and [Glu]-Fibrinopeptide B were used as calibration standards in the negative and positive modes, respectively. In the MS analysis, the Q1 is operated in RF-only mode with all ions transmitted into the pusher region of the TOF analyzer and the MS spectrum was recorded from m/z 400-2000 with 1 s integration time. For MS/MS spectra, the transmission window of quadrupole (Q1) was set up to about 3 mass units and the selected precursor ions were allowed to fragment in the hexapole collision cell. The collision energies (40-55 eV) were optimized for maximized product ion yield and argon was used as collision gas. The MS/MS data were integrated over a period of 4-5 min for each precursor ion.
DNA preparation, polymerase chain reaction (PCR) and sequencing
Gonococcal DNA was prepared from plate-grown cultures by the method of McAllister and Stephens. 33 These DNA preparations were used in PCR reactions 34 with gene-specific primers ( Table 2) to amplify the lgtABCDE genes, which were resolved by agarose gel electrophoresis as described previously; the oligonucleotide primers were designed based on the published gene sequences from strain F62 as described by Gotschlich. 21 Purified PCR products were subjected to automated DNA sequencing. Both DNA strands for each of the five genes were sequenced. The por1A and por1B genes from gonococcal strains were also amplified by PCR using oligonucleotide primers MO-Porin 5¢(5¢-CGGGATCCGCCGTCT-GAAATGAAAAAATCCCTGATTGCCCTG-3¢) and MO-Porin 3¢(5¢-CGGAATTCGCCGTCTGAATATGGA-TAGATTCGTCATTCCCGC-3¢); these primers were kindly provide by R. Nicholas (University of North Carolina, Chapel Hill, NC, USA). Regardless of which por gene allele (por1A versus por1B) was used, these primers amplified each gene equally well.
Cloning and insertional mutagenesis of lgtA
Oligonucleotide primers Lgt1 and Lgt7 (Table 2) were used to PCR-amplify a 1.2 kb DNA fragment containing the complete lgtA from chromosomal DNA prepared from strain SS-2. The PCR product was cloned into pBAD using the TOPO TA cloning kit from Invitrogen. The ligation reaction was then used to transform Escherichia coli TOPO cells (Invitrogen) and transformants were selected on Lauria Base (LB) agar containing 100 mg/ml ampicillin. Plasmid DNA was prepared from a representative transformant. This plasmid was linearized with BbsI, which recognizes a site 390 nucleotides downstream of the lgtA start codon. The non-polar promoterless aphA-3 cassette described by Menárd et al. 35 was removed from pUC18K by digestion with SmaI. The liberated aphA-3 cassette was then ligated into the linearized pBAD plasmid containing lgtA; the ends of this linearized plasmid were filled in by Klenow. After overnight ligation, the mixture was used to transform competent E. coli DH5a and transformants were selected on LB agar containing 50 mg/ml kanamycin. PCR was then used to confirm the presence of the lgtA::Km sequence in a plasmid preparation obtained from a representative transformant. The purified plasmid bearing lgtA::Km was then used to transform N. gonorrhoeae strains FA19 and SS-2 for resistance 50 Shafer, Datta, Kolli, Rahman, Balthazar, Martin et al. 
RESULTS
Electrophoretic and mAb-binding properties of LOS species produced by isogenic gonococci
In 1987, we described 19 a panel of genetic variants of NHS-resistant gonococcal strain FA19 that displayed high (e.g. strain SS-2) or intermediate (e.g. strain SS-9) levels of susceptibility to NHS (Table 1) ; NHS-killing of strains SS-2 and SS-9 required both antibody (IgM) and the classical complement pathway. Strains SS-2 and SS-9 were found to produce LOS species that were no longer reactive with mAb 2-1-L8, which recognizes the Galb1-4Glc epitope 21, [26] [27] [28] in the a-chain. On re-examination of these strains, we found that the predominant LOS species of the NHS-resistant FA19 culture ( Fig. 1 and Table 1 ) used in the isolation of these NHS-susceptible gonococcal variants was 3.6 kDa and reactive with mAb 4C4 but not 3F11 ( Fig. 1 and Table 1 ); this LOS species also reacted with mAb 2-1-L8 (data not presented). In contrast, the highly NHS-sensitive variant strain SS-2 (Table 1 ) produced a major LOS species of 4.6 kDa and a slightly larger but minor species of 4.8 kDa, both of which were recognized in Western immunoblots by mAb 3F11 but not mAb 4C4 ( Fig. 1 and Table 1 ) or mAb 2-1-L8 (data not presented). The NHSintermediately sensitive strain SS-9 ( Fig. 1 and Table 1 ) produced a 3.8 kDa LOS that was not recognized by mAbs 2-1-L8, 4C4 or 3F-11.
DNA sequence analysis of the lgtABCDE operon
Since mAb 3F11 recognizes the Galb1-4GlcNAc disaccharide in the complete lacto-N-neotetraose region of the LOS a-chain and the mAb 4C4 and 2-1-L8 epitopes are masked by this four-sugar complex, we thought that the NHS-susceptible variants of FA19 might contain differences in carbohydrates in this region of their respective LOS.
Since the enzymes needed for completion of the lacto-Nneotetraose region are encoded by the lgtABCDE operon, 21 we determined the complete nucleotide sequence of this region from strains FA19, SS-1, SS-2 and SS-9. Due to the homopolymeric G-tracts in lgtA, lgtC and lgtD, these genes have been postulated 8, 21 to be susceptible to slipped-strand mispairing events. Due to the resulting nucleotide insertions or deletions in this G-tract, the coding sequence could be phase-on or phase-off. Using primers ( Table 2 ) that permitted the amplification of overlapping regions of the five-gene complex, we were able to determine that strain FA19 contained phase-off (e.g. inactive) lgtACD genes ( Fig. 2) but had wild-type lgtB and lgtE gene sequences (data not presented).
Since lgtA encodes the N-acetylglucosamine (GlcNAc) transferase responsible for extending the LOS a-chain from the Galb1-4Glc sequence, 21 the LOS of this culture of strain FA19 would not be able to synthesize a complete lacto-Nneotetraose. In contrast, highly NHS-sensitive strain SS-2 was found to have phase-on lgtA and lgtD genes (Fig. 2) and wild-type lgtB and lgtE genes (data not presented), thus allowing it to complete the synthesis of the mAb 3F11reactive epitope in the lacto-N-neotetraose domain (Galb1-4GlcNAcb1-4Galbb1-4Glc); 21 the lgtC gene in strain SS-2 was found to be in the phase-off sequence (Fig.  2) . DNA sequence analysis of the lgtABCDE operon from NHS-intermediate strain SS-9 revealed that lgtA and lgtD were both in the phase-off position (Fig. 2 ), but lgtC was in the phase-on position; the lgtB and lgtE sequences from this strain were wild-type (data not presented). In that lgtC encodes a 1,3a-galactosyl transferase 21 that adds Gal to the Gal residue of the a-chain structure Galb1-4Glc inner core region, which would block further extension of the a-chain, we hypothesized that strain SS-9 would contain Gala1-4Galb1-4Glc as its LOS a-chain; this hypothesis was confirmed by chemical analyses of their purified LOS (see below).
Evidence for phase variation of lgtA and changes in NHS-susceptibility in gonococci
In order to ascertain whether slipped-strand mispairing events in lgtA, lgtC and/or lgtD would impact NHS-susceptibility, we selected NHS-resistant variants of strain SS-2 after two rounds of exposure to 50% (v/v) of NHS (see Materials and Methods); these variants arose at a frequency of 2 x 10 -4 . When incubated in either 33% (v/v) NHS (Table 3) or 50% (v/v) NHS (data not presented), the NHS-resistance profile of one such variant (SS-2B) was similar to that of strain FA19. It is important to note that the enhanced resistance of strain SS-2B to NHS was specific for the membrane-damaging activity generated by serum antibody and complement because it and parental strain SS-2 were equally sensitive to other membrane-damaging agents, such as polymyxin B and the human antibacterial peptide LL-37 22 (minimal inhibitory concentrations of 50 and 6.25 mg/ml, respectively). The LOS electrophoretic profile and nucleotide sequence of the lgtABCDE operon from strain SS-2B and two additional NHS-resistant variants of strain SS-2 were determined. All three NHS-resistant variants produced an LOS that was electrophoretically faster than parental strain SS-2 (4.5 kDa) but were indistinguishable from the 3.6 kDa LOS species of strain FA 19 (e.g. strain Table 1 ). Moreover, like that of strain FA19, the LOS of SS-2B and the additional NHS-resistant variants was reactive with mAb 4C4 but not 3F11 (Table 1) . DNA sequence analysis revealed a phase-off G-12 tract in their lgtA gene (see strain SS-2B in Fig. 2) , as opposed to a phase-on G-11 tract in the lgtA gene of parental strain SS-2. Similar to parental strain SS-2, the spontaneous NHS-resistant variants maintained a phase-off lgtC gene and phase-on lgtD gene (Fig. 2) and had wildtype lgtB and lgtE gene sequences (data not presented).
SS-2B in
The above data suggested that phase variation of lgtA can significantly impact the susceptibility of gonococci to the bacteriolytic action of NHS. In order to directly test whether expression of a phase-on lgtA gene is essential for the NHS-susceptible property of strain SS-2, we cloned an internal fragment of its phase-on lgtA gene and inserted the non-polar aphA-3 cassette 35 downstream of the G-11 tract; the details of this construction are described in Materials and Methods. The lgtA gene of piliated strains SS-2 (phase-on) and FA19 (phase-off) were then replaced with the lgtA::Km sequence by allelic exchange in a transformation reaction that used a plasmid construct bearing lgtA::Km. Representative lgtA::Km transformants were then screened for their susceptibility to NHS, the presence of lgtA::Km with a G-11 tract upstream of the aphA-3 cassette and their LOS electrophoretic mobility in SDS-PAGE. PCR confirmed that the lgtA gene of the Km-resistant transformants of both strains FA19 and SS-2 had been insertionally-inactivated (data not presented). DNA sequencing analyses also confirmed the presence of the G-11 tract upstream of the aphA-3 cassette (data not presented). Hence, the Km-resistant transformants of both FA19 and SS-2 contained a phase-on but insertionally-inactivated lgtA gene. SDS-PAGE of proteinase K digests of these strains revealed that the predominant LOS species produced by these transformants co-migrated with the 3.6 kDa LOS species produced by NHS-resistant strain FA19 ( Fig. 3 and Table 3 ). Most importantly, the lgtA::Km transformant of strain FA19 retained its NHS-resistance property (data not presented) and the lgtA::Km transformant (SS-2D in Table 3 ) of NHS-susceptible strain SS-2 also displayed NHS-resistance. Thus, these data are entirely consistent with the notion that expression of a wild-type phase-on lgtA gene in gonococci can contribute to NHSsusceptibility.
Chemical analyses of LOS produced by NHS-resistant and sensitive gonococci
Although the LOS electrophoretic and DNA sequencing data strongly implicated differences in the LOS that would be produced by the above-described gonococcal strains, we conducted chemical analyses on their LOSderived OSs to confirm the inferences we had drawn. Gel-filtration chromatography (Bio-Gel P2) gave only one major OS from each mild acid hydrolyzed LOS, i.e. from each of the LOSs from strains FA19, SS-2B, SS-2, and SS-9. Only one major fraction was obtained for each of these OSs. Each OS was dephosphorylated with cold aqueous 48% HF. The glycosyl compositions of these four OSs are shown in Table 4 . Both of the SS-2B and FA19 OSs had essentially the same compositions and contained galactose (Gal), glucose (Glc), L,D-heptose (Hep), and N-acetylglucosamine (GlcNAc). 3-Keto-Dmanno-2-octulosonic acid (Kdo) was present in all of the OSs, but was not quantified. Compared to SS-2B and FA19 OSs, the OS from SS-9 contained an increase in the level of Gal and the OS from SS-2 contained an increase in the levels of both Gal and GlcNAc.
The glycosyl linkage results for these OSs are shown in Table 5 . Both SS-2B and FA19 OSs had the same glycosyl linkages and contained terminally-linked Gal, 4-linked These above MS results together with the glycosyl linkage data shown in Table 5 support the conclusion that all of these OSs contained the same inner core carbohydrate structure that has been reported for a number of N. gonorrhoeae LOSs, 18, 37, 38 This inner core structure was verified by tandem MS/MS analysis of the m/z 1132 ion performed in the positive mode. The MS/MS spectrum is shown in Figure 5 together with the structure and origin of the fragment ions. This result, together with the glycosyl linkage data, shows that this ion consists of the inner core structure as shown above with R as an additional galactosyl residue. Thus, R is a galactosyl residue in both OSs from FA19 and SS-2B. The SS-9 OS preparation contains this same structure and a second major structure in which R = Gal-1®4-Gal-1-, while the SS-2 OS consists of a structure in which R = Gal-1®4-GlcNAc-1®3-Gal-1-. The structures of all these LOS-derived OSs are summarized in Figure 6 .
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The proposed structure, structure (A) in Figure 6 , for the OS from FA19 and SS-2B is consistent with the DNA sequencing data that revealed that the lgtA gene possessed by these strains would be in the phase-off sequence. While strain SS-9 also produced an OS with structure (A), the major OS consisted of structure (B) in which the additional galactosyl residue is consistent with lgtC being in the phase-on position. The proposed structure for the OS from SS-2, structure (C) in Figure 6 , is consistent with this strain having a phase-on lgtA gene that would permit the addition of GlcNAc to the a-chain b-Gal-1®4-b-Glc-1-OS portion of the LOS. The result-LOS variability and serum resistance in gonococci 55 Scheme 1. Proposed common inner core carbohydrate structure. ing a-chain trisaccharide (b-GlcNAc-1®4-b-Gal-1®4b-Glc-1-) would then act as an acceptor for the addition of terminal Gal by LgtB, 21 thereby completing the lacto-N-neotetraose structure.
The por gene possessed by NHS-resistant and sensitive gonococci
In addition to LOS structure, the production of certain allelic forms of the major gonococcal outer membrane porin (Por) has been linked to NHS-resistance. [39] [40] [41] Thus, Ram et al. 39 demonstrated that loop 5 of Por1A has the ability to bind factor H, which would down-regulate activation of the alternative complement pathway. We previously reported 19 that strain SS-2 had acquired the porB allele from NHS-sensitive donor strain FA899 and produced a PorIB9 serovar, while NHS-resistant strains FA19 and SS-1 produced a Por1A1 serovar. We had previously shown 19 that the NHS-sensitive derivatives of strain FA19 (e.g. SS-2) were killed by the classical complement pathway, making it unlikely that the Por1A versus Por1B differences between our strains significantly influenced their fate in NHS, in the manner described by Ram et al. 39 Nevertheless, since the production of Por1A serovars has been suggested to contribute to gonococcal resistance to NHS, 40, 41 we compared the por gene nucleotide sequence from strains FA19, SS-2, SS-2B so as to ensure that strain SS-2B did not have a mutation in its por sequence that might be tied to its NHS-resistant property. The deduced amino acid sequence for the loop 5 39 region derived from these por gene products confirmed our previous data 19 that strain FA19 would produce Por1A, while strain SS-2 and SS-2B would produce Por1B (Fig. 7) . Not unexpectedly, the spontaneous NHS-resistant mutant of SS-2 (strain SS-2B) maintained the parental porB nucleotide sequence (data not presented). Hence, its capacity to survive in NHS (Table 3) is more likely tied to its LOS structure ( Fig. 6 ) than its Por1B-bearing property.
DISCUSSION
The bacteriolytic action of NHS, due to serum antibody and complement, is considered to be an important host defensive system against neisserial infections, since patients with terminal complement component deficiencies 13, 14 can have repeated episodes of DGI and/or meningococcemia. Thus, for gonococci and meningococci to cause invasive bloodstream disease, it is essential that resistance to NHS-killing be expressed. The mechanism(s) by which gonococci stably resist NHSkilling has been an area of considerable study for the past 25 years. Early work, notably that of Hildebrant and co-workers, 34 implicated the possession of Por1A as being important in NHS-resistance. This hypothesis was disputed by Cannon et al. 42 and Shafer et al. 43 in their studies that revealed that loci (sac-1 + and sac-3 + ), thought to be involved with NHS-resistance or susceptibility, were closely linked but distinct from the por gene. Subsequently, Ram et al. 39 discovered that the fifth loop of Por1A could bind factor H and that this binding resulted in decreased activation of the alternative complement pathway. It is important to note, however, that the isogenic strains containing either Por1A or Por1B studied by Ram et al. 39 displayed at most a single log difference in susceptibility to NHS, as determined by the percentage of gonococci surviving during incubation in 50% (v/v) NHS for 30 min. The mechanism of NHSresistance expressed by the strains used in this study is likely to be different from that described by Ram et al. 39 First, the killing of the NHS-sensitive strain SS-2 is substantial (4 logs of killing in 50% NHS [ Table 1 ] and the nearly 3 logs of killing in 33% NHS [ Table 3 ]). Second, the difference in percent survival in NHS between the NHS susceptibility of strain SS-2 and that of NHS-resistant strain FA19 in either 33% or 50% NHS is much greater than the difference reported by Ram et al. 39 for their isogenic strains (less than one log of killing in 33% NHS). Finally, possession of Por1A is not required for NHS-resistance in our test strains since a spontaneous 56 Shafer, Datta, Kolli, Rahman, Balthazar, Martin et al. NHS-resistant mutant (SS-2B) of Por1B-bearing strain SS-2 maintained the por1B allele. It may be that the mechanism of NHS-resistance proposed by Ram et al. 39 is required under situations where alternative complement pathway activation predominates, while a Porindependent mechanism that is based on LOS structure is required when the classical complement pathway dictates NHS-killing. The capacity of gonococci to both phase and antigenically vary surface structures likely contributes to its pathogenesis. 44, 45 This ability probably helps this pathogen to interact with and invade different types of host cells, 40 infect mucosal sites that have different environmental properties and antigonococcal compounds, and to resist host defenses that are constitutively present or become available as a result of infection. Gonococci are known to produce alternative LOS structures during routine laboratory passage 11, 45 or during experimental infection. 20 Those alternative structures that appear at high frequency (10 -3 ) are thought to be the consequence of phase-variable expression of certain 8, 21, 44 lgt genes (lgtA, lgtC, lgtD and lgtG) that contain homopolymeric nucleotide repeats within their coding sequence. With respect to the biological significance of phase-variable expression of lgt genes, we have provided evidence in this report that phase-variable expression of lgtA can significantly influence the susceptibility of gonococci to NHS. A direct link between expression of a phase-on lgtA gene and NHS-susceptibility was established by insertional inactivation of this gene in NHS-susceptible strain SS-2. We found that placement of the non-polar aphA-3 cassette downstream of the G-11 sequence resulted in an NHS-resistant property in an lgtA::Km transformant (SS-2D) of NHS-susceptible strain SS-2 ( Table 3) . As evidenced by the NHS-intermediate susceptible property of strain SS-9 (Table 1) , phase-variable expression of lgtC may also impact gonococcal survival in NHS. Unfortunately due to its intermediate NHS-susceptible property, it was not feasible to isolate NHS-resistant variants of SS-9 in a manner performed with the more highly NHS-susceptible strain SS-2.
The deduced structure of 3.6 kDa LOS species produced by NHS-resistant strains FA19 and SS-2B is presented in Figure 6 . This structure is consistent with the results obtained from the chemical and linkage analyses (Tables 4 & 5) and their phase-off lgtA nucleotide sequence (Fig. 2) . This structure likely reflects the 3.6 kDa LOS Schneider et al. 17 associated with gonococcal strains obtained from patients with DGI. Presumably, during invasive bloodstream disease, the absence of natural antibody in human serum against this 3.6 kDa LOS and the presence of other bactericidal antibodies that recognize epitopes present in higher molecular weight LOS species would create a selective pressure that favors production of this 3.6 kDa LOS. Based on our findings reported herein and those of Schneider et al., 17 we analyzed the lgtA gene from three bloodstream isolates from patients with clinically-confirmed DGI. In all three instances, the lgtA gene from these strains was found to be in the phase-off sequence (data not presented). Taken together, the results presented herein favor the phase-variable expression of lgtA as a major mechanism by which the 3.6 kDa LOS species associated with NHS resistance could be produced even in strains having the genetic capacity to produce elongated LOS species.
